Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Pituitary
Erschienen in: Pituitary 6/2016

08.08.2016

Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects

verfasst von: Giuseppe Bellastella, Maria Ida Maiorino, Antonio Bizzarro, Dario Giugliano, Katherine Esposito, Antonio Bellastella, Annamaria De Bellis

Erschienen in: Pituitary | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This publication reviews the accepted knowledges and the findings still discussed on several features of autoimmune hypophysitis, including the most recently described forms, such as IgG4 and cancer immunotherapy- related hypophysitis.

Methods

The most characteristic findings and the pending controversies were derived from a literature review and previous personal experiences. A single paragraph focused on some atypical examples of the disease presenting under confounding pretences.

Results

Headache, visual field alterations and impaired pituitary secretion are the most frequent clinical findings of the disease. Pituitary biopsy, still considered the gold diagnostic standard, does not always receive consent from the patients. The role of magnetic resonance imaging is limited, as this disease may generate images similar to those of other diseases. The role of antipituitary and antihypothalamus antibodies is still discussed owing to methodological difficulties and also because the findings on the true pituitary antigen(s) are still debated. However, the low sensitivity and specificity of immunofluorescence, one of the more widely employed methods to detect these antibodies, may be improved, considering a predetermined cut-off titre and a particular kind of immunostaining.

Conclusion

Autoimmune hypophysitis is a multifaceted disease, which may certainly be diagnosed by pituitary biopsy. However, the possible different clinical, laboratory and imaging features must be considered by the physician to avoid a misdiagnosis when examining a possibly affected patient. Therapeutic choice has to be made taking into account the clinical conditions and the degree of hypothalamic-pituitary involvement, but also considering that spontaneous remissions can occur.
Literatur
1.
Cheung CC, Ezzat S, Smyth HS, Asa SL (2001) The spectrum and significance of primary hypophysitis. J Clin Endocrinol Metab 86:1048–1053PubMedCrossRef
2.
Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A (2003) Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149:363–376PubMedCrossRef
3.
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRef
4.
5.
De Bellis A, Bellastella G, Colella C, Bizzarro A, Bellastella A, Esposito K (2014) Use of serum pituitary antibodies to improve the diagnosis of hypophysitis. Exp Rev Endocrinol Metab 9:465–476CrossRef
6.
Scanarini M, d’Ercole AJ, Rotilio A, Kitromilis N, Mingrino S (1989) Giant-cell granulomatous hypophysitis: a distinct clinicopathological entity. J Neurosurg 71:681–686PubMedCrossRef
7.
Vasile M, Marsot-Dupuch K, Kujas M, Brunereau L, Bouchard P, Comoy J, Tubiana JM (1997) Idiopathic granulomatous hypophysitis: clinical and imaging features. Neuroradiology 39:7–11PubMedCrossRef
8.
Deodhare SS, Bilbao JM, Kovacs K, Horvath E, Nomikos P, Buchfelder M, Reschke K, Lehnert H (1999) Xanthomatous hypophysitis: a novel entity of obscure etiology. Endocr Pathol 10:237–241PubMedCrossRef
9.
Cosman F, Post KD, Holub DA, Wardlaw SL (1989) Lymphocytic hypophysitis report of 3 new cases and review of the literature. Medicine 68:240–256PubMedCrossRef
10.
Hassoun P, Anayssi E, Salti I (1985) A case of granulomatous hypophysitis with hypopituitarism and minimal pituitary enlargement. J Neurol Neurosurg Psych 48:949–951CrossRef
11.
Fehn M, Sommer C, Ludecke DK, Plockinger U, Saeger W (1998) Lymphocytic hypophysitis: light and microscopic findings and correlation to clinical appearance. Endocrine Pathol 9:71–78CrossRef
12.
Ahmed SR, Aiello DP, Page R, Hopper K, Towfighi J, Santen RJ (1993) Necrotizing infundibulo-hypophysitis: a unique syndrome of diabetes insipidus and hypopituitarism. J Clin Endocrinol Metab 76:1499–1504PubMed
13.
van der Vliet HJ, Perenboom RM (2004) Multiple pseudotumors in IgG4- associated multifocal systemic fibrosis. Ann Intern Med 141:896–897PubMedCrossRef
14.
15.
Goudie EB, Pinkerton PH (1962) Anterior hypophysitis and Hashimoto’s disease in a young woman. J Pathol Bacteriol 83:584–585PubMedCrossRef
16.
Simmonds M (1917) Uber das Vorkommen von Riesenzelle in der Hypophyse. Virchows Arch 223:281–290CrossRef
17.
Rupp JJ, Paschkis KE (1953) Panhypopituitarism with idiopathic hypoparathyroidism. Ann Intern Med 39:1103–1107PubMedCrossRef
18.
Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957) Chronic thyroiditis and autoimmunization. JAMA 164:1439–1447CrossRef
19.
Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14:426–430PubMedCrossRef
20.
Buxton N, Robertson I (2001) Lymphocytic and granulocytic hypophysitis: a single centre experience. Br J Neurosurg 15:242–246PubMedCrossRef
21.
22.
Rivera JA (2006) Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 9:35–45PubMedCrossRef
23.
De Bellis A, Ruocco G, Battaglia M, Conte M, Coronella C, Tirelli G, Bellastella A, Pane E, Sinisi AA, Bizzarro A, Bellastella G (2008) Immunological and clinical aspects of lymphocytic hypophysitis. Clin Sci 114:413–421PubMedCrossRef
24.
Falorni A, Minarelli V, Bartoloni E, Alunno A, Gerli R (2014) Diagnosis and classification of autoimmune hypophysitis. Autoimmun Rev 13:412–416PubMedCrossRef
25.
Gellner V, Kurschel S, Scarpatetti M, Mokry M (2008) Lymphocytic hypophysitis in the pediatric population. Childs Nerv Syst 24:785–792PubMedCrossRef
26.
Sellayah R, Gonzales M, Fourlanos S, King J (2015) Lymphocytic hypophysitis in the elderly. J Clin Neurosci 22:1842–1843PubMedCrossRef
27.
Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, Liau LM (2015) HLA markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis. J Clin Endocrinol Metab 100:4092–4097PubMedCrossRef
28.
De Bellis A, Bizzarro A, Bellastella A (2005) Pituitary antibodies and lymphocytic hypophysitis. Best Pract Res Clin Endocrinol Metab 19:67–84PubMedCrossRef
29.
De Bellis A, Bizzarro A, Bellastella A (2004) Autoimmune central diabetes insipidus. In: Green V, Chrousos G (eds) Immunoendocrinology in health disease. Marcel Dekker, New York, pp 439–459
30.
Palmer JP, Asplin CM, Clemons PL, Tatpati O, Raghu PK, Paquette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 23:1337–1339CrossRef
31.
Winqvist O, Karlsson FA, Kämpe O (1992) 21-Hydroxylase, a major autoantigen in idiopathic Addison’s disease. Lancet 339:1559–1562PubMedCrossRef
32.
33.
Beressi N, Beressi JP, Cohen R, Modigliani E (1999) Lymphocytic hypophysitis. A review of 145 cases. Ann Intern Med 150:327–341
34.
Ezza S, Josse RG (1997) Autoimmue hypophysitis. Trends Endocrinol Metab 8:74–80CrossRef
35.
Sautner D, Saeger W, Lüdecke DK, Jansen V, Puchner MJ (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol 90:637–644PubMedCrossRef
36.
Vidal S, Rotondo F, Horvath E, Kovacs K, Scheithauer BW (2002) Immunocytochemical localization of mast cells in lymphocytic hypophysitis. Am J Clin Pathol 117:478–483PubMedCrossRef
37.
De Bellis A, Colao A, Bizzarro A, Di Salle F, Coronella C, Solimeno S, Vetrano A, Pivonello R, Pisano G, Lombardi G, Bellastella A (2002) Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab 87:3825–3829PubMedCrossRef
38.
De Bellis A, Bizzarro A, Amoresano Paglionico V, Di Martino S, Criscuolo T, Sinisi AA, Lombardi G, Bellastella A (1994) Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus. Clin Endocrinol 40:173–177CrossRef
39.
Barbaro D, Loni G (2000) Lymphocytic hypophysitis and autoimmune thyroid disease. J Endocrinol Invest 23:339–340PubMedCrossRef
40.
Ermann J, Fathman CG (2001) Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol 2:759–761PubMedCrossRef
41.
Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115–1119PubMedCrossRef
42.
Todd I, Bottazzo GF (1995) On the issue of inappropriate HLA class II expression on endocrine cells: an answer to a sceptic. J Autoimmun 8:313–322PubMedCrossRef
43.
Khare S, Jagtap VS, Budyal SR, Kasaliwal R, Kakade HR, Bukan A, Sankhe S, Lila AR, Bandgar T, Menon PS, Shah NS (2015) Primary (autoimmune) hypophysitis: a single centre experience. Pituitary 18:16–22PubMedCrossRef
44.
Levy MJ, Jäger HR, Powell M, Matharu MS, Meeran K, Goadsby PJ (2004) Pituitary volume and headache: size is not everything. Arch Neurol 61:721–725PubMedCrossRef
45.
Shelly S, Boaz M, Orbach H (2012) Prolactin and autoimmunity. Autoimmun Rev 11:465–470CrossRef
46.
De Bellis A, Bizzarro A, Bellastella A (2008) Role of prolactin in autoimmune diseases handbook of systemic autoimmune diseases series. In: Asherson RA, Walker S, Jara LJ (eds) Endocrine manifestations of systemic autoimmune dieseas, vol 9 pp 29–43
47.
Nishiki M, Murakami Y, Ozawa Y, Kato Y (2001) Serum antibodies to human pituitary membrane antigens in patients with autoimmune lymphocytic hypophysitis and infundibuloneurohypophysitis. Clin Endocrinol 54:327–333CrossRef
48.
Hashimoto K, Takao T, Makino S (1997) Lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis. Endocrine J 44:1–10CrossRef
49.
Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015) Pituitary working group of the German society of endocrinology. Diagnosis of primary hypophysitis in Germany. J Clin Endocrinol Metab 100:3841–3849PubMedCrossRef
50.
Ahmadi J, Meyers GS, Segall HD, Sharma OP, Hinton DR (1995) Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases. Radiology 195:30–34PubMedCrossRef
51.
Chelaifa K, Bouzaidi K, Harzallah F, Menif E, Ben Messaoud M, Turki I, Slim R (2002) Lymphocytic hypophysitis. J Neuroradiol 29:57–60PubMed
52.
Nakamura Y, Okada H, Wada Y, Kajiyama K, Koshiyama H (2001) Lymphocytic hypophysitis: its expanding features. J Endocrinol Invest 24:262–267PubMedCrossRef
53.
Sato N, Sze G, Endo K (1998) Hypophysitis: endocrinologic and dynamic MR findings. Am J Neuroradiol 19:439–444PubMed
54.
Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P (2009) A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. Am J Neuroradiol 30:1766–1772PubMedCrossRef
55.
Unluhizarci K, Bayrom F, Colak R, Ozturk F, Selcuken A, Durak AC, Kelestimur F (2001) Distinct radiological and clinical appearance of lymphocytic hypophysitis. J Clin Endocrinol Metab 86:1861–1864PubMedCrossRef
56.
Nishiyama S, Takano T, Hidaka Y, Takada K, Iwatani Y, Amino N (1993) A case of postpartum hypopituitarism associated with empty sella: possible relation to postpartum autoimmune hypophysitis. Endocrine J 40:431–438CrossRef
57.
Klein J, Fehm HL (2005) Unusual presentation of hypophysitis preceding an empty sella in a 75-year-old woman. Neuro Endocrinol Lett 26:757–758PubMed
58.
Kelestimur F, Jonsson P, Molvalilai S, Gomez JM, Auemhanmer CJ, Colak R, Koltowska-Haggstrom M, Goth MI (2005) Shehan’s syndrome: baseline characteristics and the effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS_Pfizer International Metabolic Database. Eur J Endocrinol 152:581–587PubMedCrossRef
59.
De Bellis A, Kelestimur F, Sinisi AA, Ruocco G, Tirelli G, Battaglia M, Bellastella G, Conzo G, Tanriverdi F, Unluhizarci K, Bizzarro A, Bellastella A (2008) Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan’s syndrome. Eur J Endocrinol 158:147–152PubMedCrossRef
60.
Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633–1641PubMedPubMedCentralCrossRef
61.
Pivonello R, De Bellis A, Faggiano A, Di Salle F, Petretta M, Di Somma C, Perrino S, Altucci P, Bizzarro A, Bellastella A, Lombardi G, Colao A (2003) Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical immunological and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 88:1629–1636PubMedCrossRef
62.
De Bellis A, Bizzarro A, Rossi R, Amoresano Paglionico V, Criscuolo T, Lombardi G, Bellastella A (1993) Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab 76:1002–1007PubMed
63.
De Bellis A, Colao A, Di Salle F, Muccitelli VI, Iorio S, Perrino S, Pivonello R, Coronella C, Bizzarro A, Lombardi G, Bellastella A (1999) A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J Clin Endocrinol Metab 84:3047–3051PubMedCrossRef
64.
65.
Gluck M, Scherbaum WA (1990) Substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera. Horm Metab Res 22:541–545PubMedCrossRef
66.
Maghnie M, Lorini R, Severi F (1994) Antipituitary antibodies in patients with pituitary abnormalities and hormonal deficiency. Clin Endocrinol 40:809–810CrossRef
67.
Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 55:288–292PubMedCrossRef
68.
Tzou SC, Lupi I, Landek M, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149:3461–3469PubMedPubMedCentralCrossRef
69.
Lupi I, Broman KW, Tzou SC, Gutenberg A, Martino E, Caturegli P (2008) Novel autoantigens in autoimmune hypophysitis. Clin Endocrinol 69:269–278CrossRef
70.
71.
Smith CJ, Bensing S, Burns C, Robinson PJ, Kasperlik-Zaluska AA, Scott RJ, Kämpe O, Crock PA (2012) Identification of TPIT and other novel autoantigens in lymphocytic hypophysitis: immunoscreening of a pituitary cDNA library and development of immunoprecipitation assays. Eur J Endocrinol 166:391–398PubMedPubMedCentralCrossRef
72.
Tanaka S, Tatsumi KI, Kimuri M, Takano T, Murakani Y, Takao T, Hashimoto K, Kato Y, Amino N (2002) Detection of autoantibodies against the pituitary-specific protein in patients with lymphocytic hypophysitis. Eur J Endocrinol 147:767–775PubMedCrossRef
73.
Crock P (1998) Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab 83:609–618PubMed
74.
Tanaka S, Tatsumi KI, Takano T, Murakami Y, Takao T, Yamakita N, Tahara S, Teramoto A, Hashimoto K, Kato Y, Amino N (2003) Anti-alpha-enolase antibodies in pituitary disease. Endocrine J 50:697–702CrossRef
75.
Bensing S, Fetissov SO, Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M, Ekwall O, Crock PA, Hokfelt T, Hulting AL, Kampe O (2007) Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. Proc Natl Acad Sci USA 104:949–954PubMedPubMedCentralCrossRef
76.
Crock P, Salvi M, Miller A, Wall J, Guyda H (1993) Detection of anti-pituitary autoantibodies by immunoblotting. J Immunol Methods 162:31–40PubMedCrossRef
77.
O’Dwyer DT, Smith AI, Matthew ML, Andronicos NM, Ranson M, Robinson PJ, Crock PA (2002) Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as α-enolase. J Clin Endocrinol Metab 87:752–757PubMedCrossRef
78.
O’Dwyer DT, Clifton V, Hall A, Smith R, Robinson PJ, Crock PA (2002) Pituitary autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-Enolase—a link with pregnancy? Arch Physiol Biochem 110:94–98PubMedCrossRef
79.
Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, Suzuki H, Iwata N, Takeuchi S, Nakashima K, Takagi H, Izumida H, Ochiai H, Fujisawa H, Suga H, Arima H, Shimoyama Y, Takahashi M, Nishioka H, Ishikawa SE, Shimatsu A, Caturegli P, Oiso Y (2015) Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 100:946–954CrossRef
80.
Bando H, Iguchi G, Yamamoto M, Hidaka-Takeno R, Takahashi Y (2015) Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism. Pediatr Endocrinol Rev 12:290–296PubMed
81.
Engelberth O, Jezkova Z (1965) Autoantibodies in Sheehan’s syndrome. Lancet 1:1075CrossRef
82.
Bottazzo GF, Pouplard A, Florin-Christensen A, Doniach D (1975) Autoantibodies to prolactin-secreting cells of human pituitary. Lancet 2:97–101PubMedCrossRef
83.
Bottazzo GF, McIntosh C, Stanford W, Preece M (1980) Growth hormone cell antibodies and partial growth hormone deficiency in a girl with Turner’s syndrome. Clin Endocrinol (Oxford) 12:1–9CrossRef
84.
Mayfield RK, Levine JH, Gordon L, Powers J, Galbraith RM, Rawe SE (1980) Lymphoid adenohypophysitis presenting as a pituitary tumor. Am J Med 69:619–623PubMed
85.
Wild RA, Kepley M (1986) Lymphocytic hypophysitis in a patient with amenorrhea and hyperprolactinemia. A case report. J Reprod Med 31:211–216PubMed
86.
Komatsu M, Kondo T, Yamauchi K, Yokokawa N, Ichikawa K, Ishihara M, Aizawa T, Yamada T, Imai Y, Tanaka K (1988) Antipituitary antibodies in patients with the primary empty sella syndrome. J Clin Endocrinol Metab 67:633–638PubMedCrossRef
87.
Mau M, Phillips TM, Ratner RE (1993) Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol 38:495–500CrossRef
88.
Ricciuti A, De Remigis A, Landek-Salgado MA, De Vincentis L, Guaraldi F, Lupi I, Iwama S, Wand GS, Salvatori R, Caturegli P (2014) Detection of pituitary antibodies by immunofluorescence. Approach and results in patients with pituitary diseases. J Clin Endocrinol Metab 99:1758–1766PubMedPubMedCentralCrossRef
89.
90.
Mauerhoff T, Mirakian R, Bottazzo GF (1987) Autoimmunity and the pituitary. In: Doniach D, Bottazzo GF (eds) Endocrine and other organ-oriented autoimmune disorders. Bailliere’s Clin Immunol Allergy 1:217–235
91.
Cocco C, Brancia C, D’Amato F, Noli B (2014) Pituitary gonadotropins and autoimmunity. Mol Cell Endocrinol 385:97–104PubMedCrossRef
92.
De Bellis A, Bizzarro A, Conte M, Perrino S, Coronella C, Solimeno S, Sinisi AM, Stile LA, Pisano G, Bellastella A (2003) Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J Clin Endocrinol Metab 88:650–654PubMedCrossRef
93.
De Bellis A, Salerno M, Conte M, Coronella C, Tirelli G, Battaglia M, Esposito V, Ruocco G, Bellastella G, Bizzarro A, Bellastella A (2006) Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature. J Clin Endocrinol Metab 91:2484–2489PubMedCrossRef
94.
De Bellis A, Sinisi AA, Conte M, Coronella C, Bellastella G, Esposito D, Pasquali D, Ruocco G, Bizzarro A, Bellastella A (2007) Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 92:604–607PubMedCrossRef
95.
De Bellis A, Bizzarro A, Perrino S, Coronella C, Conte M, Pasquali D, Sinisi AA, Betterle C, Bellastella A (2005) Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine disease. Clin Endocrinol 63:45–49CrossRef
96.
Delvecchio M, De Bellis A, Francavilla R, Rutigliano V, Predieri B, Indrio F, De Venuto D, Sinisi AA, Bizzarro A, Bellastella A, Iughetti L, Cavallo L (2010) Italian Autoimmune Hypophysitis Network Study Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. Am J Gastroenterol 105:691–696PubMedCrossRef
97.
Bellastella G, Rotondi M, Pane E, Dello Iacovo A, Pirali B, Della Mora L, Falorni A, Sinisi AA, Bizzarro A, Colao A, Chiovato L, De Bellis A (2010) Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. J Clin Endocrinol Metab 95:3750–3757PubMedCrossRef
98.
De Bellis A, Sinisi AA, Pane E, Dello Iacovo A, Bellastella G, Di Scala G, Falorni A, Giavoli C, Gasco V, Giordano R, Ambrosio MR, Colao A, Bizzarro A, Bellastella A (2012) Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. Italian Autoimmune Hypophysitis Network Group. J Clin Endocrinol Metab 97:3684–3690PubMedCrossRef
99.
De Bellis A, Dello Iacovo A, Bellastella G, Savoia A, Cozzolino D, Sinisi AA, Bizzarro A, Bellastella A, Giugliano D (2014) Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarsm. Pituitary 17:457–463PubMedCrossRef
100.
De Bellis A, Colella C, Bellastella G, Lucci E, Sinisi AA, Bizzarro A, Holdaway I (2013) Late primary autoimmune hypothyroidism in a patient with postdelivery autoimmune hypopituitarism associated with antibodies to growth hormone and prolactin-secreting cells. Thyroid 23:1037–1041PubMedCrossRef
101.
Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P (2013) Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab 98:3920–3925PubMedPubMedCentralCrossRef
102.
Bellastella G, Bizzarro A, Aitella E, Barrasso M, Cozzolino D, Di Martino S, Esposito K, De Bellis A (2015) Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: description of two cases. Eur J Endocrinol 172:11–17CrossRef
103.
De Bellis A, Bellastella G, Maiorino MI, Aitella E, Lucci E, Cozzolino D, Bellastella A, Bizzarro A, Giugliano D, Esposito K (2016) Italian Autoimmune Hypophysitis Network Group. Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age. Eur J Endocrinol 174:381–387PubMedCrossRef
104.
De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8:25–30PubMedCrossRef
105.
De Bellis A, Colao A, Pivonello R, Savoia A, Battaglia M, Ruocco G, Tirelli G, Lombardi G, Bellastella A, Bizzarro A (2007) Antipituitary antibodies in idiopathic hyperprolactinemic patients. Ann N Y Acad Sci 1107:129–135PubMedCrossRef
106.
De Bellis A, Colao A, Savoia A, Coronella C, Pasquali D, Conte M, Pivonello R, Bellastella A, Sinisi AA, Bizzarro A, Lombardi G, Bellastella G (2008) Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies. Clin Endocrinol 69:285–291CrossRef
107.
Hori M, Makita N, Andoh T, Takiyama H, Yajima Y, Sakatani T, Fukumoto S, Iiri T, Fujita T (2010) Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J 57:485–492PubMedCrossRef
108.
Hirabayashi K, Zamboni G (2012) IgG4-related disease. Pathologica 104:43–55PubMed
109.
Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38:1720–1723PubMedCrossRef
110.
111.
Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96:1971–1980PubMedPubMedCentralCrossRef
112.
Hattori Y, Tahara S, Ishii Y, Kitamura T, Inomoto C, Osamura RY, Teramoto A, Morita A (2013) A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 98:1808–1811PubMedCrossRef
113.
Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, Zhang X, Tian X, Zheng W, Leng X, Xu D, Wang Q, Shen M, Wang L, Li J, Wu D, Zhao L, Wu C, Yang Y, Peng L, Zhou J, Wang Y, Sha Y, Huang X, Jiao Y, Zeng X, Shi Q, Li P, Zhang S, Hu C, Deng C, Li Y, Zhang S, Liu J, Su J, Hou Y, Jiang Y, You X, Zhang H, Yan L, Zhang W, Zhao Y, Zeng X, Zhang F, Lipsky PE (2015) Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford) 54:1982–1990CrossRef
114.
Caturegli P, Iwama S (2013) From Japan with love: another tessera in the hypophysitis mosaic. J Clin Endocrinol Metab 98:1865–1868PubMedCrossRef
115.
Torino F, Barnabei A, Paragliola RM, Marchetti P, Salvatori R, Corsello SM (2013) Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol 23:169–176
116.
Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM (2005) Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 28:593–598PubMedPubMedCentralCrossRef
117.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC (2006) Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 20:2283–2289CrossRef
118.
Yang JC, Hughes M, Kammula U, Royal R, Sherry RM, Topalian SL, Suri KB, Levy C, Allen T, Mavroukakis S, Lowy I, White DE, Rosenberg SA (2007) Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother 30:825–830PubMedPubMedCentralCrossRef
119.
120.
Maker AV, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Hughes M, Yellin MJ, Haworth LR, Levy C, Allen T, Mavroukakis SA, Attia P, Rosenberg SA (2006) Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J Immunother 29:455–463PubMedPubMedCentralCrossRef
121.
Chodakiewitz Y, Brown S, Boxerman JL, Brody JM, Rogg JM (2014) Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis. Clin Neurol Neurosurg 125:125–130PubMedCrossRef
122.
Rodrigues BT, Otty Z, Sangla K, Shenoy VV (2014) Ipilimumab-induced autoimmune hypophysitis: a differential for sellar mass lesions. Endocrinol Diabetes Metab Case Rep 2014:140098PubMedPubMedCentral
123.
Majchel D, Korytkowski MT (2015) Anticytotoxic T-lymphocyte antigen-4 induced autoimmune hypophysitis: a case report and literature review. Case Rep Endocrinol 2015:570293PubMedPubMedCentral
124.
Faje A (2016) Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary 19:82–92PubMedCrossRef
125.
126.
Lidove O, Piette JC, Charlotte F, Cassoux N, Correas JM, Papo T (2004) Lymphocytic hypophysitis with lachrymal, salivary and thyroid gland involvement. Eur J Intern Med 15:121–124PubMedCrossRef
127.
Pérez-Núñez A, Miranda P, Arrese I, González P, Ramos A, Lobato RD (2005) Lymphocytic hypophysitis with cystic MRI appearance. Acta Neurochir (Wien) 147:1297–1300CrossRef
128.
Huang YY, Lin SF, Dunn P, Wai YY, Hsueh C, Tsai JS (2005) Primary pituitary lymphoma presenting as hypophysitis. Endocr J 52:543–549PubMedCrossRef
129.
Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63:197–202CrossRef
130.
Kanoke A, Ogawa Y, Watanabe M, Kumabe T, Tominaga T (2013) Autoimmune hypophysitis presenting with intracranial multi-organ involvement: three case reports and review of the literature. BMC Res Notes 28(6):560CrossRef
131.
Jain A, Dhanwal DK (2015) A rare case of autoimmune hypophysitis presenting as temperature dysregulation. J Clin Diagn Res 9:OD09-10
132.
Koyama S, Okuno K, Naoi H, Watanabe M, Ozaki K, Shiki Y (2016) Post-partum hypoglycemia and hypothermia as first manifestations of lymphocytic adenohypophysitis: a case report. J Obstet Gynaecol Res 42:467–470PubMedCrossRef
133.
Hayashi Y, Oishi M, Kita D, Watanabe T, Tachibana O, Hamada J (2015) Pure Lymphocytic Infundibuloneurohypophysitis caused by the rupture of Rathke’s Cleft Cyst: report of 2 cases and review of the literature. Turk Neurosurg 25:332–336PubMed
134.
Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N (2002) Pituitary autoimmunity in patients with Sheehan’s syndrome. J Clin Endocrinol Metab 87:4137–4141PubMedCrossRef
135.
Tanriverdi F, De Bellis A, Bizzarro A, Sinisi AA, Bellastella G, Pane E, Bellastella A, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F (2008) Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? Eur J Endocrinol 159:7–13PubMedCrossRef
136.
Tanriverdi F, De Bellis A, Teksahin H, Alp E, Bizzarro A, Sinisi AA, Bellastella G, Paglionico VA, Bellastella A, Unluhizarci K, Doganay M, Kelestimur F (2012) Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? Pituitary 15:579–588PubMedCrossRef
137.
Larouche V, Correa JA, Cassidy P, Beauregard C, Garfield N, Rivera J (2016) Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas. Pituitary 19:202–209PubMedCrossRef
138.
Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Störmann S, Schopohl J, Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S, Elbelt U (2015) Pituitary Working Group of the German Society of Endocrinology. Treatment of primary hypophysitis in Germany. J Clin Endocrinol Metab 100:3460–3469PubMedCrossRef
139.
Schreckinger M, Francis T, Rajah G, Jagannathan J, Guthikonda M, Mittal S (2012) Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab. J Neurosurg 116:1318–1323PubMedCrossRef
140.
De Bellis A, Colella C, Bellastella G, Savoia A, Guastafierro S, Cozzolino D, Bizzarro A, Bellastella A, Giugliano D (2014) Rituximab-induced remission of autoimmune hypophysitis and primary immune thrombocytopenia in a patient with autoimmune polyendocrine syndrome type 4. Exp Rev Endocrinol Metab. doi:10.​1586/​17446651.​2014.​913979
141.
Xu C, Ricciuti A, Caturegli P, Keene CD, Kargi AY (2015) Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab. Pituitary 18:441–447PubMedCrossRef
Metadaten
Titel
Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects
verfasst von
Giuseppe Bellastella
Maria Ida Maiorino
Antonio Bizzarro
Dario Giugliano
Katherine Esposito
Antonio Bellastella
Annamaria De Bellis
Publikationsdatum
08.08.2016
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 6/2016
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-016-0736-z

Weitere Artikel der Ausgabe 6/2016

Pituitary 6/2016 Zur Ausgabe

ReviewPaper

Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies

OriginalPaper

Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing’s disease

Acknowledgments

Acknowledgement of reviewers 2015

Letter

Cushing’s disease and co-existing phaeochromocytoma

OriginalPaper

Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors

OriginalPaper

Long-term outcomes of children treated for Cushing’s disease: a single center experience

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise